000 01605 a2200457 4500
005 20250518071237.0
264 0 _c20200422
008 202004s 0 0 eng d
022 _a1545-5017
024 7 _a10.1002/pbc.28075
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWang, Shih-Chung
245 0 0 _aIntravenous immunoglobulin therapy enhances suppressive regulatory T cells and decreases innate lymphoid cells in children with immune thrombocytopenia.
_h[electronic resource]
260 _bPediatric blood & cancer
_c02 2020
300 _ae28075 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aCase-Control Studies
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aCytokines
_xmetabolism
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aImmunity, Innate
_xdrug effects
650 0 4 _aImmunoglobulins, Intravenous
_xadministration & dosage
650 0 4 _aLymphocytes
_xdrug effects
650 0 4 _aMale
650 0 4 _aPrognosis
650 0 4 _aProspective Studies
650 0 4 _aPurpura, Thrombocytopenic, Idiopathic
_xdrug therapy
650 0 4 _aT-Lymphocytes, Regulatory
_xdrug effects
700 1 _aYang, Kuender D
700 1 _aLin, Ching-Yuang
700 1 _aHuang, Alex Y
700 1 _aHsiao, Chien-Chou
700 1 _aLin, Ming-Tsan
700 1 _aTsai, Yi-Giien
773 0 _tPediatric blood & cancer
_gvol. 67
_gno. 2
_gp. e28075
856 4 0 _uhttps://doi.org/10.1002/pbc.28075
_zAvailable from publisher's website
999 _c30321845
_d30321845